A detailed history of Briggs Advisory Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Briggs Advisory Group, Inc. holds 3,130 shares of MRK stock, worth $393,910. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,130
Previous 3,220 2.8%
Holding current value
$393,910
Previous $371,000 13.21%
% of portfolio
0.18%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $9,265 - $10,289
-90 Reduced 2.8%
3,130 $322,000
Q2 2023

Jul 24, 2023

BUY
$108.61 - $118.38 $19,115 - $20,834
176 Added 5.78%
3,220 $371,000
Q1 2023

May 05, 2023

BUY
$102.94 - $114.86 $2,779 - $3,101
27 Added 0.89%
3,044 $323,000
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $263,806 - $338,235
3,017 New
3,017 $334,000
Q2 2022

Jul 22, 2022

BUY
$83.49 - $94.64 $334,711 - $379,411
4,009 New
4,009 $366,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Briggs Advisory Group, Inc. Portfolio

Follow Briggs Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Briggs Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Briggs Advisory Group, Inc. with notifications on news.